← Leaderboards
Pedro Filipe Da Costa Pinheiro
University Of Virginia
$381,486
Attributed
$381,486
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $81.6K · FY2019–24$100K$75K$50K$25K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$381,486 · 2
By mechanism
K00$312,560 · 1
F99$68,926 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Virginia
Same institution · by research overlap
- Thomas P Loughran$27,014,958
- Daniel G Gioeli$4,074,968
- Randy Allen Jones$2,462,773
- James M Larner$8,820,863
- Kevin A Janes$15,012,538
Others in their field
Other Emerging Leaders on “Career”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Prasant Mohapatra · University Of California At Davis$41,160,449
- Gary Kobinger · University Of Texas Med Br Galveston$34,500,000
- Eric C Palm · Florida State University$31,951,397
- Ross D McDonald · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
Research focus
CareerAcetatesCancer PatientAgonistAnabolismAndrogen AntagonistsAbirateroneAblationAndrogen MetabolismAndrogen ReceptorAndrogensAnimalsAnti-Cancer TherapeuticAreaAwardAndrogen Deprivation TherapyBig DataBindingBioinformatics ToolBiologyBisulfite SequencingCancer CellCancer DiagnosisCell Death
Grant awards (6)
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer$77,669
K00 · FY2024 · CA · contact PI
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer$81,642
K00 · FY2023 · CA · contact PI
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer$77,757
K00 · FY2022 · CA · contact PI
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer$75,492
K00 · FY2021 · CA · contact PI
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer$33,965
F99 · FY2020 · CA · contact PI
Ceramide NanoLiposomes as a novel therapeutic for prostate cancer$34,961
F99 · FY2019 · CA · contact PI